Ohio Public Employees Retirement System (OPERS)’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,623
Closed -$118K 2027
2022
Q1
$118K Buy
+1,623
New +$138K ﹤0.01% 1663

Other funds holding NTLA

Ohio Public Employees Retirement System (OPERS)'s NTLA Position: Q2 2022 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Intellia Therapeutics (NTLA) in Q2 2022, closing a stake of 1,623 shares — an estimated $118K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in NTLA in Q1 2022 and held it in 1 quarter. The position peaked at $118K in Q1 2022. 299 funds tracked by Wall St. Rank hold NTLA as of Q2 2022.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Intellia Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 1,623 Intellia Therapeutics shares in Q2 2022, an estimated $118K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Intellia Therapeutics in Q1 2022 and held it in 1 quarter.
  • Ohio Public Employees Retirement System (OPERS)'s Intellia Therapeutics position peaked at $118K in Q1 2022.
  • 299 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2022.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2022, filed 15 Aug 2022.